Wednesday, August 12, 2020 9:14:04 PM
$THMO | #ThermoGenesis Holdings, Upside Targets
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
Official InvestorsHub (IHUB) Profile for #TFMG | #theFinancialMarketingGroup:
#BullishCharts - https://investorshub.advfn.com/BullishChartscom-38003/
#TopMarketGainers - https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Recent THMO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 05:14:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:59:18 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/06/2023 05:15:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:30:53 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/22/2023 10:28:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 12:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 12:30:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:52:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:35:12 PM
- ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 11/13/2023 09:05:00 PM
- ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update • PR Newswire (US) • 11/08/2023 01:31:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2023 05:13:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/26/2023 09:03:35 PM
- ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento • PR Newswire (US) • 10/26/2023 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 07:27:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 12:33:42 AM
- ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference • PR Newswire (US) • 09/06/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 04:53:19 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 08/14/2023 08:27:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:35:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:15:02 PM
- ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 08/10/2023 08:05:00 PM
- ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update • PR Newswire (US) • 08/08/2023 07:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 09:12:43 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM